John Reed (Jeff Rumans for Endpoints News)
November 18, 2021 01:30 AM ESTUpdated 06:34 AM
Deals
AI

Sanofi inks ma­jor AI deal to im­prove clin­i­cal de­vel­op­ment odds with $270M cash in­vest­ment

Paul Schloesser

Associate Editor

John Carroll

Editor & Founder

For most of the up-and-com­ing AI play­ers in the biotech space, we’ve seen a slew of deals to uti­lize AI and ma­chine learn­ing in drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times